Ekso Bionics (EKSO) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. MRNA
10. SPCX

Go back to Ekso Bionics (EKSO) Misses Q4 EPS by 2c

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

March 28, 2023 4:26 PM EDT

SAN RAFAEL, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2022.

Recent Highlights and Accomplishments

Completed the acquisition of the Human Motion Control (HMC) business unit including the Indego® product line from Parker Hannifin CorporationGenerated revenue of $12.9 million for the 2022 full year, an increase of 15% year-over-yearBooked a total of 100 EksoHealth devices for the 2022 full year, including Indego bookings... More